vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.

OCEANEERING INTERNATIONAL INC is the larger business by last-quarter revenue ($692.4M vs $487.7M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). OCEANEERING INTERNATIONAL INC runs the higher net margin — 5.2% vs -10.1%, a 15.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 3.6%). CLOVER HEALTH INVESTMENTS, CORP. produced more free cash flow last quarter ($-69.0M vs $-76.5M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 1.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.

CLOV vs OII — Head-to-Head

Bigger by revenue
OII
OII
1.4× larger
OII
$692.4M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+41.2% gap
CLOV
44.7%
3.6%
OII
Higher net margin
OII
OII
15.3% more per $
OII
5.2%
-10.1%
CLOV
More free cash flow
CLOV
CLOV
$7.5M more FCF
CLOV
$-69.0M
$-76.5M
OII
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
1.8%
OII

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
OII
OII
Revenue
$487.7M
$692.4M
Net Profit
$-49.3M
$36.1M
Gross Margin
Operating Margin
-10.1%
Net Margin
-10.1%
5.2%
Revenue YoY
44.7%
3.6%
Net Profit YoY
-123.2%
-28.3%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
OII
OII
Q1 26
$692.4M
Q4 25
$487.7M
$668.6M
Q3 25
$496.6M
$742.9M
Q2 25
$477.6M
$698.2M
Q1 25
$462.3M
$674.5M
Q4 24
$337.0M
$713.5M
Q3 24
$331.0M
$679.8M
Q2 24
$356.3M
$668.8M
Net Profit
CLOV
CLOV
OII
OII
Q1 26
$36.1M
Q4 25
$-49.3M
$177.7M
Q3 25
$-24.4M
$71.3M
Q2 25
$-10.6M
$54.4M
Q1 25
$-1.3M
$50.4M
Q4 24
$-22.1M
$56.1M
Q3 24
$-9.2M
$41.2M
Q2 24
$7.4M
$35.0M
Gross Margin
CLOV
CLOV
OII
OII
Q1 26
Q4 25
19.8%
Q3 25
20.6%
Q2 25
21.3%
Q1 25
20.0%
Q4 24
19.9%
Q3 24
24.5%
19.3%
Q2 24
30.3%
18.0%
Operating Margin
CLOV
CLOV
OII
OII
Q1 26
Q4 25
-10.1%
9.8%
Q3 25
-4.9%
11.6%
Q2 25
-2.2%
11.3%
Q1 25
-0.3%
10.9%
Q4 24
-6.4%
10.9%
Q3 24
-2.7%
10.5%
Q2 24
2.0%
9.0%
Net Margin
CLOV
CLOV
OII
OII
Q1 26
5.2%
Q4 25
-10.1%
26.6%
Q3 25
-4.9%
9.6%
Q2 25
-2.2%
7.8%
Q1 25
-0.3%
7.5%
Q4 24
-6.6%
7.9%
Q3 24
-2.8%
6.1%
Q2 24
2.1%
5.2%
EPS (diluted)
CLOV
CLOV
OII
OII
Q1 26
$0.36
Q4 25
$1.75
Q3 25
$0.71
Q2 25
$0.54
Q1 25
$0.49
Q4 24
$0.55
Q3 24
$0.40
Q2 24
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
OII
OII
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
$488.8M
Stockholders' EquityBook value
$308.7M
$1.1B
Total Assets
$541.0M
$2.6B
Debt / EquityLower = less leverage
0.44×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
OII
OII
Q1 26
Q4 25
$78.3M
$695.9M
Q3 25
$7.0M
Q2 25
$7.0M
Q1 25
$7.0M
Q4 24
$194.5M
$504.5M
Q3 24
$288.0M
Q2 24
$254.8M
Total Debt
CLOV
CLOV
OII
OII
Q1 26
$488.8M
Q4 25
$487.4M
Q3 25
Q2 25
Q1 25
Q4 24
$482.0M
Q3 24
Q2 24
Stockholders' Equity
CLOV
CLOV
OII
OII
Q1 26
$1.1B
Q4 25
$308.7M
$1.1B
Q3 25
$340.9M
$907.7M
Q2 25
$344.2M
$842.1M
Q1 25
$336.1M
$773.1M
Q4 24
$341.1M
$714.3M
Q3 24
$342.2M
$698.0M
Q2 24
$324.9M
$651.0M
Total Assets
CLOV
CLOV
OII
OII
Q1 26
$2.6B
Q4 25
$541.0M
$2.7B
Q3 25
$559.7M
$2.5B
Q2 25
$575.0M
$2.3B
Q1 25
$583.7M
$2.3B
Q4 24
$580.7M
$2.3B
Q3 24
$653.0M
$2.4B
Q2 24
$674.2M
$2.3B
Debt / Equity
CLOV
CLOV
OII
OII
Q1 26
0.44×
Q4 25
0.46×
Q3 25
Q2 25
Q1 25
Q4 24
0.67×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
OII
OII
Operating Cash FlowLast quarter
$-66.9M
Free Cash FlowOCF − Capex
$-69.0M
$-76.5M
FCF MarginFCF / Revenue
-14.1%
-11.1%
Capex IntensityCapex / Revenue
0.4%
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
OII
OII
Q1 26
Q4 25
$-66.9M
$221.1M
Q3 25
$12.1M
$101.3M
Q2 25
$5.4M
$77.2M
Q1 25
$-16.3M
$-80.7M
Q4 24
$34.8M
$128.4M
Q3 24
$50.0M
$91.9M
Q2 24
$44.8M
$52.6M
Free Cash Flow
CLOV
CLOV
OII
OII
Q1 26
$-76.5M
Q4 25
$-69.0M
$190.7M
Q3 25
$11.4M
$77.0M
Q2 25
$4.8M
$46.9M
Q1 25
$-16.5M
$-106.8M
Q4 24
$33.3M
$94.5M
Q3 24
$49.6M
$67.0M
Q2 24
$44.4M
$29.8M
FCF Margin
CLOV
CLOV
OII
OII
Q1 26
-11.1%
Q4 25
-14.1%
28.5%
Q3 25
2.3%
10.4%
Q2 25
1.0%
6.7%
Q1 25
-3.6%
-15.8%
Q4 24
9.9%
13.2%
Q3 24
15.0%
9.9%
Q2 24
12.5%
4.5%
Capex Intensity
CLOV
CLOV
OII
OII
Q1 26
2.5%
Q4 25
0.4%
4.6%
Q3 25
0.1%
3.3%
Q2 25
0.1%
4.3%
Q1 25
0.0%
3.9%
Q4 24
0.5%
4.7%
Q3 24
0.1%
3.7%
Q2 24
0.1%
3.4%
Cash Conversion
CLOV
CLOV
OII
OII
Q1 26
Q4 25
1.24×
Q3 25
1.42×
Q2 25
1.42×
Q1 25
-1.60×
Q4 24
2.29×
Q3 24
2.23×
Q2 24
6.04×
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons